Skip to main content
Palgrave Macmillan

Valuations of Early-Stage Companies and Disruptive Technologies

How to Value Life Science, Cybersecurity and ICT Start-ups, and their Technologies

  • Book
  • © 2020

Overview

  • Simplifies the mathematical and economic techniques employed in corporate valuations in general, and those for ventures at developmental and early-growth stages
  • Draws on a number of interdisciplinary insights when evaluating early-stage ventures, specifically psychological insights into investor/entrepreneur behavior at different intervals throughout the valuation process
  • Explores circumstantially specific valuation conundrums and how to treat these analytically

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 44.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 69.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (15 chapters)

  1. A Short Overview of Valuations

  2. Overcoming Valuation Hurdles: How to Conduct Valuations Under Unique Circumstances

  3. Behavioral Factors: How Psychology Affects Bias in Valuations

  4. An Introduction to Valuations in R&D-Intensive Industries

  5. Actual Valuations

Keywords

About this book

This book will serve as a practical guide for entrepreneurs and investors/advisors in constructing and understanding valuations of startups in rapidly shifting industries, including the areas of drug development, medical devices, cyber security, and renewable energy. For large companies, valuation is based on forecasts of free cash flow; in technologically-driven industries, product pipelines can represent a large part of market capitalization. The situation is even more critical for small companies committed to a single idea: all of their value is linked to a single project. Any business transaction or internal proposal to begin or terminate an R&D project in which innovative projects are being valued or exchanged requires a realistic valuation of those projects. Moreover, different projects have very different dynamics. Pharmaceuticals have very large lead times and are dependent on patents as well as out-licensing agreements. In contrast, software develops very quickly, and IP is hard to value. This book will be a guide to building appropriate valuations for companies competing in rapidly shifting industries and offering products under new business models where little precedent exists, taking both financial and behavioral issues into consideration.


Reviews

“Tiran Rothman has written a must-read practical book for any technology firm or investor who wishes to acquire an in-depth understanding of the valuation process of tech companies.” (David Frigstad, Chairman, Frost & Sullivan)

“Psychological aspects of decision making are playing an increasing role in economic modeling and valuation, adding positive elements to the traditional approach based on the standard economic assumptions of rationality. Tiran Rothman book will guide investors and analysts with this exact convergence of behavioral economics and valuation for early-stage firms, where cognitive bias may play a significant rule.” (Itzhak Venezia, Professor of Finance (Emeritus), Hebrew University, Israel; Editor of Behavioral Finance: Where do Investors Biases Come From?)

“Tiran Rothman’s book highlights the excitement around the surge of theoretical and practical work in behavioral finance. A variety of readers are targeted with this book—lay people that seek to better understand how to analyze early-stage companies and practitioners interested in applying psychological aspects when they construct and value new securities.” (Joakim Westerholm, Professor of Finance, University of Sydney Business School, Australia)

“Tiran Rothman has written a path-breaking book on financial valuation firmly grounded in the latest research on behavioral finance and investor psychology. He goes far beyond abstract theory and shows practically how to value early- and mid-stage firms in R&D-heavy sectors like the life sciences. The book includes a plethora of examples of valuing real-world startups. Tiran’s work is an indispensable guide for students and practitioners of valuation alike. Highly recommended!” (Joshua Mitts, Associate Professor, Columbia University)

Authors and Affiliations

  • Tel Aviv, Israel

    Tiran Rothman

About the author

Tiran Rothman has over a decade of experience in financial consultancy and academic and applied research in behavioral finance and economics. As a vice president of Frost & Sullivan, he leads the largest private financial valuation program for high-tech companies and the Tel Aviv Stock Exchange Equity Research Program, involving pharmaceutical, biotechnology, medical device, ICT, renewable energy, autonomous vehicle and cybersecurity companies. He previously served as the Chief Economist of AMPAL (NASDAQ: AMPL). Tiran is also an Assistant Professor at the WIZO Academic Center Haifa in Israel. He holds a PhD in Behavioral Economics from the University of Haifa, an MBA in Finance from IDC Herzliya and was a visiting fellow at New York University’s Stern Business School. He has published widely in the field of behavioral finance and has been the recipient of numerous research grants and scholarships.

Bibliographic Information

  • Book Title: Valuations of Early-Stage Companies and Disruptive Technologies

  • Book Subtitle: How to Value Life Science, Cybersecurity and ICT Start-ups, and their Technologies

  • Authors: Tiran Rothman

  • DOI: https://doi.org/10.1007/978-3-030-38847-8

  • Publisher: Palgrave Macmillan Cham

  • eBook Packages: History, History (R0)

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2020

  • Hardcover ISBN: 978-3-030-38846-1Published: 28 November 2020

  • Softcover ISBN: 978-3-030-38849-2Published: 28 November 2021

  • eBook ISBN: 978-3-030-38847-8Published: 27 November 2020

  • Edition Number: 1

  • Number of Pages: XII, 219

  • Number of Illustrations: 6 b/w illustrations, 5 illustrations in colour

  • Topics: Investment Appraisal, Risk Management, Start-Ups/Venture Capital, Innovation/Technology Management, Cybercrime

Publish with us